| 81/163 | US=57 / Biol/Mol Weinberg RA. p53 e apoptose: guardião e executor. In: ___. A biologia do câncer. Porto Alegre: Artmed, 2008. p. 307-56. ISBN 978-85-363-1348-1. P53; APOPTOSE; PAPOVAVIRUS; MUTACAO DE P53; ALEDOS MUTANTES HERDADOS; CELULAS CANCEROSAS |
| 82/163 | US=67 / Biol/Mol Knights CD, Pestell RG. The cell cycle: therapeutic targeting of cell regulatory components and effector pathways in cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 3-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CICLO CELULAR; SEGMENTACAO TERAPEUTICA; COMPONENTES CELULARES; VIAS REGULADORAS; CANCER; CICLINA DEPENDENTE DE QUINASE; INIBIDORES CDK; TERAPIA; ACETILACAO; P53; CICLINA D1; EGFR; HDAC; STI-571; FLAVOPIRIDOL; INIBIDOR CDK2 |
| 83/163 | US=58 / Câncer Kuang J, Wang R. Mechanisms of G2 phase arrest in DNA damage-induced checkpoint response. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 37-51. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. G2 CHECKPOINT; CDC25; PP2A; 14-3-3; 14-3-3O; P53; P21; GADD45 |
| 84/163 | US=58 / Câncer Lee MH, Yeung SCJ, Yang HY. Interplay of 14-3-3 family of proteins with DNA damage-regulated molecules in checkpoint control. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 69-80. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. FAMILIA DE PROTEINAS COM 14-3-3; DANOS AO DNA; RESPOSTA CHECKPOINT; 14-3-3; AKT; MDM2; P53; DANOS NO DNA |
| 85/163 | US=58 / Câncer Nakanishi M. Chromatin modifications and orchestration of checkpoint response in cancer. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 83-93. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. MODIFICACOES DE CROMATINA; ORQUESTRACAO DE RESPOSTA; CONTROLE EM CANCER; CHK1; CHK2; P53; REPLICACAO DO DNA |
| 86/163 | US=58 / Câncer Kaina B, Roos WP, Christmann M. DNA damage response and the balance between cell survival and cell death. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 95-108. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; SOBREVIVENCIA CELULAR; MORTE CELULAR; CHECKPOINTS; CICLO CELULAR; RESPOSTA A DANOS DO DNA; REPARACAO DO ADN; P53; APOPTOSE; RECEPTORES DE MORTE; FAS; CAIXA ELETRONICO; ATR; DROGAS ANTICANCER |
| 87/163 | US=58 / Câncer Post SM, Quinás-Cardama A, Lozano G. Regulation of p53 activity and associated checkpoint controls. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 171-88. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. P53; MDM2; P19; TUMORIGENESE; CANCER; RAS; CICLO CELULAR; RB; CICLINA; CDK |
| 88/163 | US=58 / Câncer Eastman A. The importance of p53 signaling in the response of cells to checkpoint inhibitors. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 189-98. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; PARADA DO CICLO CELULAR; P53; P21; CICLINA B; CHK1 INIBIDORES; UCN-01; INIBIDORES DA TOPOISOMERASE II; ANALOGOS DE NUCLEOSIDOS |
| 89/163 | US=70 / Biol/Mol Bunz F. Tumor suppressor genes. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 77-124. ISBN 978-1-4020-6783-9. GENES SUPRESSORES DE TUMORES; FENOTIPO RECESSIVO; RETINOBLASTOMA; HIPOTESE DE KNUDSON; LOCALIZACAO CROMOSSOMICA DO GENE; INATIVACAO DO P53; SINDROME DE LI-FRAUMENI; SUSCETIBILIDADE; CANCER DE MAMA; BRCA1; BRCA2; CDKN2A; PTEN; SMAD4; NEUROFIBROMATOSE; NEOPLASIA ENDOCRINA MULTIPLA TIPO 1; SINDROMES DE CANCER EM CAMUNDONGOS |
| 90/163 | US=70 / Biol/Mol Bunz F. Cancer gene pathways. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 173-226. ISBN 978-1-4020-6783-9. CANCER; GENE; VIAS; VIAS CELULARES; INTERACAO PROTEINA-PROTEINA; REACOES BIOQUIMICAS; FOSFORILACAO DE PROTEINAS; SINAIS DA SUPERFICIE CELULAR; TIROSINA-QUINASES PROTEICAS; VIA RAS; FOSFORILACAO DE LIPIDIOS; VIA PI3K/AKT; MORFOGENESE; VIA WNT/APC; HOMEOSTASE; ATIVACAO P53; MDM2; APOPTOSE; CICLO CELULAR |
| 91/163 | US=80 / Biol/Mol Lee K, Wang T, Rehman A, Wang Y, Daoud SS. Cell signaling proteomics: integration of genomics and proteomics in dissecting p53 signaling. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 39-57. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. FARMACOGENOMICA; PROTEOMICA; P53; S100A4; RB18A; CANCER DO COLON |
| 92/163 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 93/163 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 94/163 | US=86 / Biol/Mol Kuribayashi K, El-Deiry W. Regulation of programmed cell death by the P53 pathway. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 201-21. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. REGULACAO DA MORTE CELULAR PROGRAMADA; VIA P53; APOPTOSE; TRANSCRICAO; RECEPTORES TRAIL; MORTE CELULAR DEPENDENTES DE P53 |
| 95/163 | US=111 / Câncer Bourdon JC, Lane DP. p53 family pathway in cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 272-81. ISBN 978-0-470-01852-1. |
| 96/163 | US=36 / Gastro Kelly CR, Wands JR. Molecular biology of liver carcinogenesis and hepatitis. In: Blumgart LH. Surgery of the biliary tract, and pancreas. 4th ed. Philadelphia: Elsevier Saunders, 2007. p. 153-63. (v.1) ISBN 978-1-4160-3256-8. BIOLOGIA MOLECULAR DE CARCINOGENESE DO FIGADO; BIOLOGIA MOLECULAR DE HEPATITE; VIRUS DA HEPATITE B; VIRUS DA HEPATITE C; P53 GENE SUPRESSOR DE TUMOR E AFLATOXINAS; TELOMERO ENCURTAMENTO; TRANSDUCAO DE VIAS DE SINALIZACAO |
| 97/163 | US=46 / Câncer La Thangue NB. Theoretical foundations of cancer chemotherapy. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 369-87. ISBN 978-3-527-31768-4. CANCER; QUIMIOTERAPIA; DESENHO DE DROGAS; TERAPIA; P53; CICLO CELULAR; ANGIOGENESE; HSP90; ERB B; E2F |
| 98/163 | US=49 / Câncer Joerger AC, Fersht R. Structural biology of the tumor suppressor p53 and cancer-associated mutants. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 1-23. ISBN 978-0-12-006697-1. BIOLOGIA ESTRUTURAL DO GENE SUPRESSOR TUMORAL P53; GENE SUPRESSOR TUMORAL P53; MUTACAO DO CANCER |
| 99/163 | US=49 / Câncer Wilman KG. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 321-38. ISBN 978-0-12-006697-1. FUNCAO DE P53; TUMORES HUMANOS DE TIPO SELVAGEM; TERAPIA DO CANCER EFICIENTE; REACCAO DE MUTACAO DO P53; VIRUS TERAPEUTICO |
| 100/163 | US=77-J / Câncer Ikemori RY, Saito RF. Alterações metabólicas envolvidas no desenvolvimento tumoral. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 142-9. ISBN 8-5866523-7-0. CANCER; DESENVOLVIMENTO TUMORAL; ALTERACOES METABOLICAS; GLICOLISE AEROBIA; EFEITO WARBURG; HIF-1; PI3K/AKT/MTOR; P53; MYC; LACTATO DESIDROGENASE; GLUTAMINA; BIOSSINTESE DE LIPIDEOS; FARMACOS |